Unilateral Dominance of Lower Limb Movement from the Perspective of Force Exertion and Operability (Neurosensory, General Presentation, 63rd Annual Meeting of the Japanese Society of Physical Fitness and Sports Medicine)

This study investigated the cardiometabolic effects of bromocriptine in men with prolactin excess, comparing those with early-onset androgenic alopecia (group 1) to those with normal hair growth (group 2). Over 4 months, both groups received bromocriptine treatment. While both groups experienced reductions in prolactin, increases in testosterone, and improvements in insulin sensitivity, group 2 showed stronger improvements in these areas and additional benefits such as increased HDL cholesterol and decreased triglycerides, fibrinogen, and UACR. The study concluded that men with early-onset androgenic alopecia were partially resistant to the cardiometabolic benefits of bromocriptine.